Study links higher microplastic levels to lung cancer diagnosis

We don't yet know what happens once they enter the human body.
Dr. Dimeas acknowledges the fundamental uncertainty underlying the research on microplastics and lung disease.
Mark

So they found more microplastics in lung cancer patients. Does that mean microplastics cause lung cancer?

Mimi

Not necessarily. The study shows a correlation—cancer patients had higher microplastic burdens—but correlation isn't causation. The researchers themselves say diseased lungs might just trap particles differently than healthy ones.

Luke

Right, and that's the honest part of the reporting. They found 232 particles across 100 people. That's not a huge number. And we're comparing 66 percent detection in cancer patients to 46 percent in non-cancer patients. That's a real difference, but it's not overwhelming.

Mark

What are these microplastics actually doing in the lungs?

Mimi

That's the open question. They could trigger inflammation that contributes to disease. Or they could just sit there. The particles they found were mostly polypropylene and polyethylene—common plastics from packaging and textiles. We're all breathing them in.

Luke

The study is observational, not experimental. They looked at what was already in people's lungs. They can't tell us whether the microplastics arrived before the cancer developed or after. That matters for causation.

Mark

So what happens next?

Mimi

The team is studying patients with chronic lung diseases to see if microplastics play a role in scarring and disease progression. They're also doing lab work to understand how plastics interact with lung cells.

Luke

And they're being careful about what they claim. Dimeas says explicitly that we don't yet know background levels, how much they vary, or whether they contribute to disease. That's the right posture when the evidence is still early.

Mark

Is this something people should worry about?

Mimi

It's worth paying attention to. We're breathing microplastics every day. Whether they cause cancer or other diseases is still being determined. But the fact that they're in our lungs at all is a reason to think about air quality and plastic pollution.

Luke

The advocacy angle is cleaner than the science angle right now. Professor Hoffmann called it a fundamental human right to breathe clean air. That's true regardless of what microplastics ultimately do to us.

  • Lung cancer patients in the study showed a 66% microplastic detection rate in lung samples compared to just 46% in non-cancer patients — a gap that demands explanation.
  • The sheer quantity of particles, not just their presence, was significantly higher in cancerous lungs, intensifying concern that accumulation itself may matter.
  • Researchers cannot yet determine whether microplastics drive disease or whether damaged lungs simply trap particles more readily — a critical distinction that current methods cannot resolve.
  • An unexpected inverse pattern emerged: patients with more microplastics in their airspaces had fewer embedded in tissue, suggesting uneven, poorly understood distribution throughout the lung.
  • Teams are now expanding into chronic lung disease populations and laboratory cell studies, racing to move the science from correlation toward mechanism before public health policy can respond.

In a study presented at the European Respiratory Society Congress in Barcelona, Greek researchers examining lung samples from 100 patients found that those diagnosed with lung cancer carried measurably higher concentrations of microplastics than those without the disease — a correlation that does not yet establish cause, but deepens humanity's reckoning with what it means to breathe in a world saturated with synthetic materials. The particles most commonly found, polypropylene and polyethylene, are the same plastics woven into the fabric of everyday life. Science stands at the threshold of a question it cannot yet fully answer: whether these invisible fragments are witnesses to disease, or among its architects.

A team of researchers in Greece examined lung samples from 100 patients undergoing bronchoscopy and found a troubling pattern: those diagnosed with lung cancer carried significantly more microplastics in their lungs than those without the disease. The findings were presented at the European Respiratory Society Congress in Barcelona, adding momentum to growing concern about the health consequences of inhaling plastic particles.

The study drew on two types of samples — lung-wash fluid, where saline is flushed through lung tissue to collect debris, and direct tissue biopsies from fifty of the patients. Across all 100 participants, 232 microplastic particles were identified in total, with 70% of patients showing detectable levels. But when the groups were separated, the difference was stark: 66% of lung cancer patients had microplastics in their samples, compared to 46% of those without cancer. More significantly, the total burden — the sheer quantity of particles — was considerably higher in the cancer group. Polypropylene and polyethylene, the plastics most common in packaging and textiles, were the dominant types found.

Lead researcher Dr. Ilias Dimeas was careful to hold the findings at arm's length from any causal claim. Whether microplastics provoke inflammation or other processes that contribute to cancer, or whether diseased lungs simply retain particles differently than healthy ones, remains unknown. Adding to the complexity, an inverse relationship emerged between airspace and tissue samples from the same patients — those with more particles in their airspaces tended to have fewer embedded in tissue — suggesting microplastics settle unevenly depending on location and lung condition.

Professor Barbara Hoffmann of the European Respiratory Society placed the research within the broader landscape of lung disease, noting that lung cancer kills 1.8 million people annually and that air pollution is already a recognized contributor. Microplastics, she suggested, represent a new and largely unmapped dimension of what we breathe. Dimeas and his team are now analyzing samples from patients with chronic lung diseases and running laboratory experiments on how different plastics interact with lung cells. The study does not prove causation — but it establishes that microplastics are present in human lungs far more often than assumed, and that their presence tracks with disease in ways that science has only begun to examine.

A team of researchers examining lung samples from 100 patients in Greece has found something troubling: people diagnosed with lung cancer carry significantly more microplastics in their lungs than those without the disease. The discovery, presented at the European Respiratory Society Congress in Barcelona, adds weight to a growing concern that the tiny plastic particles we inhale daily may pose a genuine threat to human health.

The study was straightforward in design but invasive in execution. Each of the 100 patients undergoing bronchoscopy—a procedure where doctors thread a thin camera down into the lungs to examine tissue and collect samples—participated in the research. Half the group provided lung-wash samples, where saline solution is flushed through a section of lung to collect cells and debris. In fifty of the patients, researchers also extracted small tissue samples directly from the lung itself. When the results came back, fifty of the patients had been diagnosed with lung cancer, and fifty had not.

Across all samples, the researchers identified 232 microplastic particles in total. Seventy percent of all patients had detectable microplastics somewhere in their lungs. But the pattern shifted sharply when the researchers separated the two groups. Among lung cancer patients, 66 percent showed microplastics in their lung-wash samples. Among those without cancer, the figure dropped to 46 percent. More striking still: when researchers tallied the total microplastic burden—the sheer quantity of particles—lung cancer patients carried a significantly higher load.

Dr. Ilias Dimeas of University College Dublin and the University of Thessaly, who led the research, emphasized the fundamental uncertainty beneath these findings. "We don't yet know what the background levels of microplastics in the lungs are, how much they vary from person to person, or whether they contribute to disease," he said. The particles themselves were identifiable: polypropylene and polyethylene dominated, the same plastics found in everyday packaging, textiles, and consumer goods. But the mechanism remained opaque. Do microplastics trigger inflammation or other biological processes that lead to cancer? Or do diseased lungs simply trap and hold particles differently than healthy ones? The study could not answer that question.

One detail hinted at complexity. When researchers compared lung-wash and tissue samples from the same individual, they noticed an inverse relationship: patients with more microplastics in their airspaces tended to have less embedded in the tissue itself, and vice versa. This suggested that microplastics do not distribute evenly throughout the lung, that different regions may retain particles in different ways. The picture emerging was not of a uniform exposure but of a patchwork, with particles settling unevenly depending on location and perhaps on the state of the lung tissue itself.

Professor Barbara Hoffmann, chair of the European Respiratory Society's Advocacy Council and not involved in the research, placed the findings in a wider context. Lung cancer kills 1.8 million people annually worldwide, she noted, with smoking remaining the dominant cause. But air pollution now ranks as a known contributor to lung cancer and to other respiratory diseases like asthma and chronic obstructive pulmonary disease. Microplastics, she suggested, represent a new frontier in understanding what we breathe and what it does to us. "Research on the health effects of microplastics is still at a very early stage," she said, "but we are starting to realise that these tiny pieces of plastic are infiltrating many parts of the body."

Dimeas and his team are already moving forward. They are analyzing samples from patients with chronic lung diseases to see whether microplastics play a role in lung scarring and disease progression. They are also conducting laboratory experiments to understand how different types of plastics interact with lung cells. The study does not prove that microplastics cause lung cancer. What it does show is that they are present in human lungs far more often than many people realize, and that their presence correlates with disease. That correlation is enough to raise urgent questions—questions that will require years of careful research to answer.

Microplastics have become an unavoidable part of our environment, but we still know remarkably little about what happens once they enter the human body.
— Dr. Ilias Dimeas, University College Dublin and University of Thessaly
We need more research to fully understand their potential role in lung diseases, including cancer. In the meantime, we advocate for the fundamental human right to breathe clean air.
— Professor Barbara Hoffmann, European Respiratory Society Advocacy Council
Contattaci Domande frequenti